Johnson & Johnson Development Corporation (JJDC) is the strategic venture capital division of Johnson & Johnson. They focus their investments across pharmaceutical, medical devices and consumer healthcare sectors at all stages. Their investments take a long-term approach in which they use the resources of Johnson & Johnson to support their companies, which includes discovery, clinical development, regulatory affairs, manufacturing and commercialization.
Investment
Johnson & Johnson Development Corporation has made investments in CVRx, Grail, Fusion Pharmaceuticals, Brainsgate, ReVision Optics, CoAxia, Cala Health and PhaseBio Pharmaceuticals.
They exited their investments in NovoCure, Nevro, Inspire Medical Systems, Biocartis, Mazor Robotics, Aduro BioTech, PowerVision, Neotract, Genocea Biosciences, Merus, PhaseBio Pharmaceuticals and Protagonist Therapeutics.
Timeline
Funded Companies
A biopharmaceutical company developing T cell vaccines and immunotherapies
Rodin Therapeutics is a biotechnology company developing treatments for Alzheimer's disease that is headquartered in Cambridge, Massachusetts and was founded in 2013 by Ankit Mahadevia and Martin Jefson.
Nevro is a Menlo Park, California-based biotechnology company.
Binx Health Limited is a developer of point-of-care testing platforms.
A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders
Intio is a Broomfield, Colorado-based diagnostic tools company focused on diagnostics for oncology.
Mitralign is a Tewksbury, Massachusetts-based company.
People
Asish K. Xavier
Vice President
Chris Picariello
President
Jeanne Bolger
Vice President
Marian Nakada
Vice President
Tamir Meiri
Senior Manager
V. Kadir Kadhiresan
Vice President
Vijay Murthy
Principal
Zeev Zehavi
Vice President
